Alpha Tau Medical DRTS
NASDAQ DRTS
$13.48 +0.39 (+2.98%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alpha Tau Medical (DRTS) Current Deferred Revenue (2026)

Updated

Alpha Tau Medical (DRTS) recorded Current Deferred Revenue of $18.88 million in the quarter ended Jun 30, 2026.

Analysis

Alpha Tau Medical (DRTS) Current Deferred Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Alpha Tau Medical 1.09 Bn 986.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.88 Mn
API Access

Alpha Tau Medical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DRTS&period=max&api_key=YOUR_API_KEY